Shopping Cart
- Remove All
Your shopping cart is currently empty
Glu-urea-Lys TFA(1025796-69-3 free base)
Catalog No. T8925L
Glu-urea-Lys TFA (1025796-69-3 free base) is a PSMA inhibitor.
Glu-urea-Lys TFA(1025796-69-3 free base)
Catalog No. T8925L
Glu-urea-Lys TFA (1025796-69-3 free base) is a PSMA inhibitor.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 2 mg | $50 | In Stock | |
| 5 mg | $62 | In Stock | |
| 10 mg | $88 | In Stock | |
| 25 mg | $159 | Backorder | |
| 50 mg | $226 | Backorder | |
| 100 mg | $324 | Backorder | |
| 1 mL x 10 mM (in DMSO) | $86 | In Stock |
Bulk & Custom
Add to Cart
Questions
View MoreInhibitors Related to "Glu-urea-Lys TFA(1025796-69-3 free base)"
DL-Mannitol
Mannitol
T495987-78-5
DL-Mannitol is a osmotic diuretic, it may play a role in reducing off-target 68Ga-PSMA renal uptake
- $29
Size
QTY
DUPA
N,N''-Carbonylbis[L-glutamic acid], (2S,2'S)-2,2'-Carbonylbis(Azanediyl)Dipentanedioic Acid
T19301302941-52-2
DUPA (N,N''-Carbonylbis[L-glutamic acid]) is used as the targeting moiety to actively deliver DTX for treatment of Prostate-Specific Membrane Antigen (PSMA) expressing prostate cancer.
- $37
Size
QTY
Glu-urea-Lys
T89251025796-69-3
Glu-urea-Lys is a molecular scaffold that targets PSMA and can be used as a prostate cancer imaging agent to study prostate-specific membrane antigens.
- $195
Size
QTY
DUPA(OtBu)-OH
T111221026987-94-9
DUPA(OtBu)-OH is a precursor of DUPA, which is used as a targeting moiety to actively deliver Docetaxel (DTX) for treating Prostate-Specific Membrane Antigen (PSMA) expressing prostate cancer, with PSMA showing high affinity for DUPA (Ki = 8 nM).
- $29
Size
QTY
PSMA-11
Psma-hbed-CC, PSMA11, HBED-CC-PSMA
T284661366302-52-4
PSMA-11 (HBED-CC-PSMA) detects prostate cancer recurrence and metastasis by binding to the extracellular structural domain of prostate-specific membrane antigen (PSMA).PSMA-11 is often used as a tracer of PSMA-expressing tumours in positron emission tomography (PET) scanning by intravenous injection of gallium Ga 68-labelled PSMA-11, Glu-urea-Lys(Ahx) molecule targeted and bound PSMA-expressing tumour cells. After internalisation, PSMA-expressing tumour cells could be detected on PET imaging.
- $147
Size
QTY
Vipivotide tetraxetan
PSMA-617
T125731702967-37-0
Vipivotide tetraxetan (PSMA-617) is a highly potent inhibitor of prostate-specific membrane antigen (PSMA) with a Ki of 0.37 nM.
- $193
Size
QTY
PSMA-ALB-56
T398312306049-48-7
PSMA-ALB-56 is a PSMA-targeting radioactive ligand with antitumor activity, composed of glutamic urea PSMA binding entities, DOTA chelating agents, and albumin binders based on 4-(p-iodophenyl)- fragment or p(tolyl)- fragment.
- $1,328
Size
QTY
Select Batch
Purity:99.91%
Contact us for more batch information
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.Product Introduction
Bioactivity
Chemical Properties
| Description | Glu-urea-Lys TFA (1025796-69-3 free base) is a PSMA inhibitor. |
| Molecular Weight | 433.34 |
| Formula | C14H22F3N3O9 |
Storage & Solubility Information
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 65 mg/ml (150 mM)  | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Keywords
Preview
Related Tags: buy Glu-urea-Lys TFA(1025796-69-3 free base) | purchase Glu-urea-Lys TFA(1025796-69-3 free base) | Glu-urea-Lys TFA(1025796-69-3 free base) cost | order Glu-urea-Lys TFA(1025796-69-3 free base) | Glu-urea-Lys TFA(1025796-69-3 free base) chemical structure | Glu-urea-Lys TFA(1025796-69-3 free base) formula | Glu-urea-Lys TFA(1025796-69-3 free base) molecular weight
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.